WallStreetZenWallStreetZen

NASDAQ: INM
Inmed Pharmaceuticals Inc Stock Ownership - Who owns Inmed Pharmaceuticals?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Inmed Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Adar1 Capital Management LLC10% Owner2026-09-168,340$1.29
$10.75kBuy
Adar1 Capital Management LLC10% Owner2026-09-1554,256$1.30
$70.42kBuy
Adar1 Capital Management LLC10% Owner2026-09-1428,505$1.29
$36.89kBuy
Vivo Opportunity LLC10% Owner2026-07-1619$1.55
$29.45Buy
Vivo Opportunity LLC10% Owner2026-07-162$1.55
$3.10Buy
Vivo Opportunity LLC10% Owner2026-07-151,389$1.55
$2.15kBuy
Adar1 Capital Management LLC10% Owner2026-07-151,000$1.56
$1.56kBuy
Vivo Opportunity LLC10% Owner2026-07-1513,761$1.55
$21.33kBuy
Vivo Opportunity LLC10% Owner2026-07-14493$1.55
$764.15Buy
Vivo Opportunity LLC10% Owner2026-07-144,882$1.55
$7.57kBuy

1 of 4

INM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INM insiders and whales buy or sell their stock.

INM Shareholders

What type of owners hold Inmed Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Adar1 Capital Management LLC22.27%1,223,550$1.69MInsider
Vivo Opportunity LLC14.89%818,076$1.13MInsider
Shane Aaron Johnson10.61%583,023$804.57kInsider
Eric A. Adams0.80%43,959$60.66kInsider
Andrew Hull0.70%38,258$52.80kInsider
Bruce Colwill0.21%11,515$15.89kInsider
Adar1 Capital Management LLC0.01%800$1.10kInstitution
Adar1c0.01%800$1.10kInstitution
Vivoca0.01%798$1.10kInstitution
Vivo Capital LLC0.01%798$1.10kInstitution

1 of 3

INM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INM0.05%49.48%Net BuyingNet Buying
CURX0.01%99.99%
SKYE0.00%100.00%Net SellingNet Selling
IMNN0.00%100.00%Net BuyingNet Buying
CNSP0.02%78.74%Net Buying
View Top Biotech Stocks

Inmed Pharmaceuticals Stock Ownership FAQ

Who owns Inmed Pharmaceuticals?

Inmed Pharmaceuticals (NASDAQ: INM) is owned by 0.05% institutional shareholders, 49.48% Inmed Pharmaceuticals insiders, and 50.47% retail investors. Adar1 Capital Management LLC is the largest individual Inmed Pharmaceuticals shareholder, owning 1.22M shares representing 22.27% of the company. Adar1 Capital Management LLC's Inmed Pharmaceuticals shares are currently valued at $1.69M.

If you're new to stock investing, here's how to buy Inmed Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.